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1. Introduction 
Since its global appearance, the Human Immunodeficiency Virus (HIV) has represented the 
most evident tear between bioethics/rhetoric and the reality of everyday life. 
All AIDS related issues are different in two macro areas, the first pertains to the clinical-
psychological aspect, the other a psycho-social dimension. 
The first derives from the consideration of current disease and health, and the second one 
focuses primarily on prevention and spread of the disease, considering that the only way to 
effectively fight AIDS is by preventing contagion. Over the past years, the approach towards 
AIDS has changed, from being seen as a social sore to a social-sanitary alarm, this in a 
certain way has favored the perception of the illness, which now is no longer necessarily 
associated with death. 
However something from the past has managed to survive, medicine and science have both 
evolved, and there have been numerous studies that highlight the process related to the 
disease, but the psychosocial perception has not changed, damaging who is affected finding 
themselves fighting against stigma, prejudice and exclusion. 
AIDS is not only an illness, but moreover configured as an attack on civil society, so those 
affected by it are removed or living in a constant state of discrimination, even if behind 
media campaigns and legislative measures aimed at supporting their quality of life. 
The AIDS epidemic infected more than 50 million and has claimed the lives of more than 20 
million people worldwide; its devastating effect is particularly seen in the Third World.  
Sub-Saharan Africa is the epicenter of HIV, with 67% of the 33 million infected with HIV in 
the world and with 75% of deaths due to AIDS (UNAIDS, 2008). 
In eastern and southern Africa, infant mortality is one third to two thirds higher than it 
would have been in the absence of HIV and AIDS, and child mortality continues to rise, 
leading to a dramatic reduction in life expectancy (De Cock et al., 2000). 
Currently the progression of the infection in Western countries is slowing down, both 
because of the use of more effective therapies and the improvement of information and 
prevention of infection, and thanks to greater attention paid to early diagnosis.  
Furthermore, the rate of neonatal transmission is only about 2% thanks to the introduction 
of antiretroviral drugs and the use of elective Caesarean section. 
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However the world is divided into two different approaches concerning HIV infected and 
AIDS, while in western countries they are slowly abandoning the concept (Ehrenkranz et al., 
2009) of exceptionalism, in developing countries this is still the most common approach. 
In the meantime, screening tests are performed when requested by the patient only after he 
or she has signed a formal consent form and after having gone through formal counseling; 
this means that in Africa where there is a higher prevalence of this infection, one out of five 
are not aware of their status (World Health Organitation [WHO, 2008). 
The opt-out testing is still the subject of heated debate between the philosophical currents of 
consequentialism, liberalism and free paternalism; however there is no denying that the 
consequences in terms of social impact, although heavy, collide with the benefits of a 
precocious intervention which results in being a survival rate for those infected  (April, 
2010).  
Such a chronic, infectious disease offers tremendous opportunities for ethical dilemmas and 
psychosocial discussions. Our job will be to face different topics about the HIV infection. 
2. Clinical research  
The clinical trials are increasingly conducted globally and Sponsors tend to shift their 
activities to developing countries where they can save between 10-50% of their investment 
compared to the rest of industrialized countries. 
Moreover, in countries described as "poor", the laws are less stringent due to a low 
possibility of checkups and it being easier to enlist patients (Altavilla, 2010) for which, often, 
researching is the only way to obtain drugs. The European Medicines Agency set up a Work 
on Third Country Clinical Trials in order to clarify the ethical standards used in clinical 
trials conducted outside the European Economic Area and which were then introduced to 
the European market. 
The validity of the regulations of good clinical practice is universally recognized, however, 
there is no denying that they have a different impact between Western countries and so-
called developing countries. 
Even the simple definition of standard of care and treatment, essential for the comparison of 
innovative therapies, qualitatively absorbs different connotations when assessed in the 
Western health care system compared to the rest of the world. 
In addition to the traditional principles of Bioethics, HIV/AIDS has added new issues, like: 
accessibility, affordability, standard of care, stigma and discrimination, post-trial benefits, 
equity and sustainability of interventions, that have generated intense debates both locally 
and internationally, which nevertheless, did not reach universal ethical standards in the 
world. 
Indeed, the expansion of studies on HIV throughout the world has helped the issue of the 
adaptation of ethical standards emerge even more, developed in industrialized countries, 
and exported to developing countries. 
One thing is certain, the potential imbalances in various countries and between 
communities/groups within countries demand that ethically acceptable clinical trials and 
strategies are planned in different locations so that communities and countries in need of 
early interventions can be benefited. 
It is no coincidence that the debate on the ethnicity of carrying out clinical trials in 
developing countries in search of a land "more pliable" is still ardently and culminated in 
the publication of multiple guidelines from the developed worlds (National Bioethics 
Advisory Commission [NBAC, 2001), (Nuffield Council on Bioethics, 1999). 
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In this regard the HIV Preventive Trial Network (HPTN) Ethics guidance document 
developed by HPTN Ethics Working Group of Family Health International (HIV Prevention 
Trials Network [HPTN, 2003) has addressed the crucial points of the clinical trial in the so-
called "host countries", ranging from the reduction of risk associated with stigmatization, to 
ensure informed consent for complex research with potentially vulnerable participants, from 
determining ethical authority and accountability in international collaborative research to 
design research that meets local needs as challenges. 
Incidentally the social contexts and cultural specifications of the host communities and 
countries should be given due consideration to protect the dignity, safety and welfare of the 
trial participants (Indian Council of Medical Research, 2000), when it intends to undertake a 
study of international cooperation, remembering that many countries, such as India (ICRM, 
2001), the Philippines (Philippines National Health Council, 2001) and South Africa (South 
Africa Code of Ethics, 2000), have developed their own guidelines to suit the local 
requirements. 
A typical problem of studies made in poor countries is related to the testing design, because 
while in industrialized countries generally a comparison between new and old 
pharmaceuticals is made, in developing countries it is rather difficult to find a 
pharmaceutical of control, therefore it is preferable placebo confrontation or research with a 
lower dosage or short-term studies. 
Under this aspect, not even Helsinki's 2008 version managed to reach global agreement. 
Another peculiar aspect of clinic trials held in developing countries, is represented by the 
vigorous debate of the necessity to guarantee drug coverage to all of those who take part in 
the experimentation, after of course having finished the study.  
Since 2000, researchers, pharmaceutical companies and international bioethics bodies have 
engaged in a fierce debate on access to post-treatment trials, culminating in note 30 of the 
Declaration of Helsinki (World Medical Association, 2004) – which recommends that access 
to treatments for all participants-and the 2005 European Directive (Commission Directive, 
2005), which requires foreseeing the cures that will be adopted after the study right from the 
initial protocol. 
Specifically, US National Institutes of Health Division of AIDS (National Institutes of Health 
[NIH) and other international Organizations, such as Council for International 
Organizations of Medical Sciences (Council for International Organizations of Medical 
Sciences [CIOMS, 2002) and United Nations Programme on HIV/AIDS (United Nations 
Programme on HIV/AIDS [UNAIDS, 2001), only state that post-trial access to medications 
and medical care should be “considered” in the trial planning process. 
Indeed, the hesitation of the pharmaceutical dispensing of drugs after the study is due to the 
need to fill the shortage of adequate health structures well beyond the scheduled period of 
experimentation. In other words, the Sponsors, attracted by low costs of running an 
experiment in developing countries, would ultimately leave that decision on the burden of 
dispensing post-trials (Weijer & LeBlanc, 2006). 
According to the UNAIDS report of 2010 (UNAIDS, 2010), the average price of the most 
common regimens for an adult is about US$ 0.17 per day (the cost of condoms has also 
declined to as low as US$ 0.04 per unit); while stopping a single case of infection among 
infants now costs a mere US$ 5.  
Besides economical reason many Authors (Macklin, 2001) (Grady, 2005) believe that 
constituting post-trial services would mean trial sponsors would have to take on many 
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responsibilities, so it would be preferable to perform this task having already appointed a 
government agency or a non-profit entity with larger budgets. 
However many International research ethics guidelines do not specify how post-trial 
services should be organized and a simple hint is not enough to solve the problem, seeing as 
every drug has its own specific risk and each one possible beneficence should be taken into 
consideration.  
Whether a post-trial service is present or not should be the topic of the information given to 
the patient in order to avoid false hopes, which would then undermine the expression of 
consent.  
Currently, trials conducted on antiretroviral drugs do not have the explicit reference to post-
trials service as a standard or rule in the Protocol or in the information given to the person 
who is undergoing clinical trials (Ciaranello et a., 2009). 
In this regard, it is wisely stressed “the burden and benefit of any collaborative study should 
be equally borne by the collaborating countries”; besides “Guidelines, rules, regulations and 
laws of the participating and sponsoring countries should be equally respected” 
(Muthuswamy, 2005). 
The testing of vaccines is another area of heated controversy, which already has several 
critical issues in the industrial world, but becomes exacerbated in developing countries. 
The above HPTN guidance document (developed by the Ethics Working Group) 
emphasizes protecting the vulnerable from exploitation, promoting equality through non 
discriminating access to the benefits of research and minimization of research related harms 
including medical, psychological, social and economic harms. 
However, each of these aspects opens new scenarios that did not find unanimous consent, 
even more so if we turn our attention to the experiments carried out on pregnant women or 
infants, which, however, we will discuss in the next section. 
The last aspect of the clinical trial, in general, concerns the lack of studies on palliative care 
and end-of-life in patients with AIDS. 
In this area the differences between industrialized countries and developing countries is 
dramatically incurable; to understand the difference, just think that a comparative study 
carried out on terminally ill patients in Kenya and the United Kingdom, pointed out that 
first it was more important to quell the pain while the latter played a primary role of 
emotional pain. 
As Harding et al emphasizes (Harding et al., 2003), there are five critical elements that a 
clinical trial should consider, namely: availability of pain relieving drugs, pain and 
symptom control, access to services, extent of coverage programs, education and training 
(including clinical, administrative and other skills), identification of relevant needs and 
determination of outcomes for care at the community level, and evaluation of the impact of 
education of policy makers and program directors about palliative and end-of-life care 
(sometimes termed advocacy); furthermore relevant outcomes may include policy, strategy, 
sustainability, availability and utility of education and training, and integration of end-of-
life care into health systems. 
The context of deaths in developed and developing countries are different, and context 
matters in end-of-life care. 
In industrialized countries, people die of cancer and cardiovascular diseases, in developing 
countries, HIV / AIDS, TB and malaria cause over 300 million illnesses and more than 5 
million deaths each year (WHO, 2000). As a result, projects in support of the terminally ill 
need to be different. As Singer and Bowman well debate (Singer & Bowman, 2002), the 
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discussion of quality end-of-life care points out that there is a lack of information about the 
current state of end-of-life care among populations; and this should be seen as a global 
public health problem, because “it seems difficult to know how to improve quality end-of-
life care without any understanding of what the current level of quality is, what determines 
it, and how improvement could be measured”. 
This is even more interesting considering that we are entering the third and fourth decade of 
HIV-infected, which now have a longer life expectancy thanks to current therapies. 
2.1 Cultural barriers  
HIV prevention trials conducted among disadvantaged vulnerable at-risk populations in 
developing countries present unique ethical dilemmas. 
The inclusion of participants from under-represented or vulnerable populations calls for 
special consideration because the interests of those populations may conflict with clinical 
trial objectives (Fouad et al., 2004). 
This is especially true when the object of research may cause a degree of stigma for the 
participating population. Generally, people with HIV are excluded for various reasons, 
some because they fall into illegal-behavior (for example injection drug users or sex 
workers); others because they are members of an ethnic minority; many have served time in 
jail or prison; many are poor.  
Protection against discrimination and stigmatization is an important issue with regard to 
recruiting HIV/AIDS people, so appropriate composition and training of the monitoring 
recruitment team are particularly relevant to successful recruitment; besides basic comfort at 
the study site is fundamental.  
Next to a perfect organization for what regards the technical aspects of the implementation 
of a clinical study, it is essential to pay particular attention to the specific characteristics of 
clinical research conducted on this disease. 
Basic ethical principles when recruiting study participants include respect for persons, 
beneficence and justice (Beauchamp & Childress, 1994), but for this illness, confidentiality 
and providing safety from abuse are critical. 
So the definition of ethical guidelines on the approach to these patients, with particular 
attention to the confidentiality of data, is essential. 
First, a statement about maintaining confidentiality should be included in the informed 
consent letter, guaranteeing the rights of participants to maintain control over access to 
information about their health status. 
About McNutt et al. (McNutt et al., 2009), “research participants commonly provide limited 
waivers of confidentiality for many studies. These waivers may be for protected information 
to be provided to researchers (eg, medical records) or disclosed among research participants 
(ex: research on couples or family counseling). 
In these situations, participants typically provide waivers of confidentiality that are limited 
to requirements for good scientific research”; so if the requirements for research 
participation are unacceptable, then individuals can choose not to participate. 
Certainly, a study to be ethically valid, must also be scientifically valid and unfortunately 
introducing a selection bias, only enlisting groups of patients who accept in full the 
questions of the study, may adulterate the results. 
On the other hand, to ensure dignified treatment, it should be guaranteed that study 
participants are treated with full respect for their dignity and their rights as persons. 
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Dignity, which may be defined as an achievement or acquisition, not only depends on the 
individual but also on the other surrounding people who either directly or indirectly 
interact with the subject (May, 1991). 
Unfortunately in the current management of HIV infection is not ethical, the individual 
loses his dignity, because his rights as a human being are being undermined. 
HIV/AIDS affects the most intimate rights (Chummar, 2008) of free expression, such as, life, 
health, physical expression of love, transforming relationships, requiring a physical and 
metaphorical wall between man and man. 
This social tear then clashes with the territory's culture and economy exacerbating the 
individual's difficulty to manage the disease and the intervention policies against the spread 
of infection. 
Universal Declaration on Human Rights states that health is a right and that it must be 
preserved by States (Article 25), but this remains a purely theoretical exercise, where there 
are places that lack of food and water to ensure minimum subsistence. 
Yet, prevention programs and the same international clinical research depart from a 
European conception of the individual, and therefore end up clashing with local realities, 
especially when they have totally different approaches to society by the Western schematics. 
The implementation of consent to clinical research, preventive vaccine trials and trials 
preventing vertical disease transmission, had been influenced by several factors like family-
centered decision-making; cultural dynamics pertaining to sex; relationship to older persons 
and the care-giving arrangement.  
Furthermore, some principles of individual informed consent may not be in keeping with 
the cultural norms and practices of non-Western societies. 
The requirements of Good Clinical Practice require that the enrollment of a patient in a 
clinical trial is preceded after giving clear and comprehensive information before taking the 
consent. 
Unfortunately, if you do not have any knowledge of the concept of clinical trials, as in many 
developing countries, enlistment should be preceded by an intensive information campaign 
on the basis of research (randomized placebo, responsibilities and rights of the Promoter 
and the participant etc.) before explaining the protocol study (El Sadr & Capps, 1992). 
All this implies the willingness and patience to really want to inform those undergoing 
clinical trials, as well as clearly being an economic burden for the implementation of 
information plans, considering the low cultural level which is bound to be encountered. 
Moreover, these problems are not easily foreseen by Sponsors who do not include 
considerations for cultural factors, age, gender and social-economic status in their 
recruitment strategies . 
As a result, many social needs (such as lack of funds for public transport, food etc) prevent 
their most needy patients to participate in clinical trials; still, in the most depressing areas 
you will find therapeutic misconception (Slack, 2005), bringing the subject to agree 
undergoing a clinical trial for a vaccine with the illusion of being able to heal the infection. 
Vaccine research is challenging on many fronts and has become the subject of many debates 
(Guenter, 2000). The case of Kenya AIDS Society vs Arthur Obel (Kenya AIDS, 1997), the 
Nyumbani incident (Siringi, 2004), the HIV net 012 trials carried out in Uganda (Ahn, 2003) 
and the debate on the use of placebo during International clinical trials (CIOMS, 2002), are 
only a few of the examples that testify the complexity of the ethical implications in vaccine 
trials. The vaccine guidelines provide for Community Advisory Board (CAB), whose role is 
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to facilitate community support for vaccine research and to disseminate information to the 
community hosting the research. 
In order to avoid growing skepticism in the community, Oduwo (Oduwo, 2009) suggests 
facing the issue regarding vaccine trials focusing attention mainly towards:“a detailed 
analysis of the dutie in each role should be done to resolve duplicities and conflicts among 
the roles; the legal frame work for HIV vaccine research trials and the legal basis for each 
should be clarified; discussions on HIV vaccine trials ought to be encouraged, particularly 
domestic perspectives as they may provide a nuanced appreciation of the challenges of 
research environment; the role of state to facilitate and sponsor HIV vaccine research, which 
is expressed in the HIV vaccine sub-committee and its interaction in the research framework 
may benefit from further analysis and discussion”. 
There is therefore the general tendency to exclude women - especially if pregnant-from the 
clinical trial, forgetting that in fact they are being denied treatment. 
Furthermore, the different hormone levels do not permit a full correspondence between the 
results obtained in men and those obtained in woman. 
The Department of Health and Human Services has prohibited the enlistment of pregnant 
women except in cases where the fetus is exposed to a risk or minimal risk necessary 
(Federal Register, 1978). The International guidelines (World Medical Association, 2000) for 
the protection of the subjects in experimentation do not however exclude either fertile 
women nor pregnant women from the trials, even though recognizing the extra caution that 
must be taken (45 C.F.R. §46 Subpart B, 2002). 
For fear of repercussions on the fetus many drugs are not tested in pregnant women or even 
on fertile women. In fact, the consequence is that these drugs will enter the health care 
practices that have no knowledge of how to use them. 
The same Declaration of Helsinki (Edinburgh version, 2000) states that "the purpose of 
biomedical research must be to improve the diagnostic, therapeutic and prophylactic 
methods and understanding of the etiology and pathogenesis of diseases" (art. 4) . 
The lack of reliable data makes it even more complex manage health in everyday life, since it 
authorizes the use of drugs not tested in extreme situations. 
The situation is even more complex for HIV/AIDS; for example, the process of the zivudine 
drug was troubled long before its arrival and authorized in pregnant women. 
Since 1987, when the FDA approved the use of the drug in adults with a concentration of 
CD4 + cells <200 mmc, it was not until 1994 (Morb Mortal Wkly Rep, 1994) that a study was 
created to show how the incidence of vertical transmission of HIV had reduced, with 
adequate safety for the fetus. 
In this case, the precautionary principle referred all the fetuses of women who took 
antiretroviral drugs to risk, however, in the absence of any experimental data on these risks. 
Many pregnant women, as in this case, have comorbidities besides the HIV infection and do 
not have adequate data available making their clinical management more difficult. 
Kass et al. (Kass et al., 2000). claim in this regard that clinical decisions should always be 
taken with caution knowing that what the health of pregnant women needs is usually what 
is in the best interest of the developing fetus. 
The problem of the recruitment of women in clinical trials, besides the scientific and 
economic justification, is dictated, in poor-countries, especially by cultural barriers. 
While the presence of children does not allow them to make appointments on time, those 
that a search require, on the other, their involvement is strongly influenced by the 
willingness of men (husbands, fathers or sons) to subsidize their existence. 
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In fact, women have little freedom to make decisions under the lack of economic 
independence which is often associated to a cultural level so low, as not to guarantee self-
determination. Besides this in many communities there is also the belief that being pregnant 
imposes fidelity onto the women and the use of contraceptive methods stimulate betrayal 
(Mills et al., 2006). 
2.2 Participants’ autonomy 
Diminished study participant’s autonomy is a common phenomenon in poor-resource 
countries. 
The principle of autonomy is based on the assumption that a capable person, that is capable 
of self-determination, can responsibly make a free choice, deciding on everything that 
concerns him, outside of any external interference or overlap. The principle of patient self 
determination links the person who gives his consent to research in the field of HIV, to the 
person who first receives the information about the disease in question, and the research 
itself; all of this because it is dealing with a person who realizes what is happening.  
A reduced range of candidates for research is a common phenomenon in developing 
countries in relation to the problem of obtaining adequate informed consent in these 
populations. In these countries the application of the research comes up against a 
widespread low-level socio-cultural phenomena with wide margins and a general attitude 
of distrust towards the helpers. 
This may lead to a reduced perception of the fundamental aspects of research, with a low 
level of awareness about the candidate's proposed procedures and a general lack of grip of 
the population participating in the trial. 
For these reasons, the research aimed towards people in developing countries must take into 
account the possible interference of some specific aspects, culturally mediated, that may 
influence the perception and understanding of issues related to the risk of HIV infection and 
consequently the autonomy of decision making. 
It is true that there is a universal ethics of human research but it is true that the application 
and interpretation of general ethical principles must take into account, as stated above, the 
specific factors of stakeholders, such social conventions, the cultural factors and economic 
conditions. 
In developing countries, where access to specialized care is very difficult, HIV infection is 
usually depicted as a hopeless disease, which inevitably causes suffering and death. 
This leads to a dissonance than the messages that speak of a disease potentially preventable 
and controllable. 
In each country, and sometimes in each ethnic group in that country, operators encounter 
different interpretations of medicine, illness, sexuality, death, shame, reputation; they have 
to deal with strong differences in male and female roles, and are confronted with diverse 
cultural beliefs about AIDS. 
In some populations, for example, the idea persists that certain blood groups or some people 
are immune to the virus, or that a god may protect certain individuals more than others. 
Information on the trial, then follow a general pattern where, instead, each ethnic group has 
its own rules and beliefs that dictate the expression of pain, the description of the symptoms 
and how to communicate, beliefs about the causes of the disease, expectations about the 
prevention and the practical aspects. 
The range of choices of participants in the HIV trial is, in essence, linked to personal 
variables (personality and socio-cultural characteristics) and environmental (presence of an 
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adequate social support and in particular the presence of emotionally significant people; 
characteristics of the facility and ability of professionals dedicated to building a relationship 
of empathy, understanding and containment). 
Mannheim (Mannheim, 1999) points out that there should be no constraints for which the 
patient or, more generally the free man, should feel constrained in those actions that Goethe 
had described as the "moving through the various domains of human activity” (Stuart 
Huges, 1967). According to Wilson (Wilson, 2007), in medical ethics when it comes to 
autonomy three different concepts are evoked: "the ability to make autonomous choices" 
free choices and "sphere of privacy decision-making" (meaning "with respect to those 
decisions made without coercion and interference of third parties "). There are those who 
think at the time information is received, as when news is given, which puts the subject in a 
position to express a decision in line with their values. Yet the right of veto in which one 
substantiates, is not automatically to be respected, because one might be faced with arbitrary 
decisions. 
2.3 Illiteracy, language difficulties or inadequate information 
Language barriers, as well, raise significant concerns with regard to candidates’ full 
comprehension of the technical, product and methodological information of the research 
should be adapted to the context of the developing world or poor people as well, where 
certainly the notions of ‘chance’, of ‘inactive medical”. 
The central role of autonomy of the person involved in the research is based on the 
information that should include the necessary input, appropriate to his level of knowledge, 
to enable him to actively take part in the various decisions. 
The normal asymmetry of information between doctor and patient reaches the apex of 
developing countries in relation to the lower socio-cultural level and communication 
difficulties for the difference in language (and sometimes between different tribes of the 
same country) and cultural barriers. This state of affairs can induce operators to a mere 
provision of a technical piece of information rather than to create a real relationship of 
communication. Often the research subjects are not able to understand the purpose, or know 
the process in which they concretely provide their consent, merely to accept some form of 
treatment as an alternative to the lack of access to care. 
In this case what is being acquired by non-consensus is actually invalid because it is 
underlying information implemented by a consensus but no qualifying adjectives that can 
not demonstrate the ability of the participant in the choice of self-determination. 
It is therefore necessary to build a common language within the physician-patient 
relationship through interventions that facilitate conflict resolution and help overcome the 
cultural barriers that impede communication. 
Researchers often work with the community leader to explain the research to the people and 
obtain informed consent. This expedient however is not sufficient and it is desirable that 
operators of the trial not only enrich their education in the field of HIV but also of 
transculture. 
They must increase their awareness of cultural, religious, social and political factors that 
have an impact on patients' lives, fleeing from interpreting according to their own frame of 
reference, dealing with their own prejudices and stereotypes, confronting them directly. 
They must also learn how to translate the discomfort of the patient in their own cultural 
language and return the message in a language that the patient is able to understand. 
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3. Status of affected women, young girls and/or pregnant women 
The situation of women and cultural context is tragic. 
Over the years, 'AIDS is increasingly becoming a disease of gender, in fact, more and more 
women are infected by the disease, 56% of the population ill are women between 15 and 49 
years old. 
A disease that is differentiating between the sexes not only in developing countries but also 
in Europe. 
In fact, in 2007, over 30% of people who contract the disease are women and one of the main 
predisposing factors is the risk behavior of their partner. 
According to WHO (WHO, 2000), HIV transmission from man to woman in a sexual 
relationship has double the chance of contracting it than the transmission from woman to 
man, with a greater risk for young women. 
The impact of disease on women in all aspects of life and women living with HIV are very 
influenced by the country itself, in all spheres in which they are involved, from the family to 
take care of their health. 
Excluding Western society (where at least formally) there is equality between man and 
woman, in many traditional cultures there is a subordination of the female gender towards 
the male gender. This implies a sort of tolerance in women to sexual violence, including 
both at home and away, exposing them to a higher risk of becoming infected with HIV. 
Moreover, the inability to support themselves, restricts the freedom even in sexual matters, 
so they are forced to give in to having physical relationships with people already knowingly 
infected. If, however, polygamy exists, albeit in a system free from violence, the risk of 
infection increases, particularly given the common practice of sexual gratification with sex 
workers and husbands living away from their wives and whom for economic reasons, can 
not get home during the weekend. 
In addition, the superstition that having sexual intercourse with a virgin provides immunity 
from the HIV infection, generating real rats of adolescents and children, even at a very early 
age. Still today, in refugee camps women and girls are victims of violence by their own 
armed forces that should be defending them, or rather they are "prey" of the barbaric 
savagery of the soldiers during the civil wars, as it happened in Rwandai (Fynn, 2010), 
where it is estimated that 250,000 to 500.00 "ETIN rapes" had occurred. 
The food is, then, the main reason for surrender in unprotected sex for women, as they may 
engage in transactional sex to procure food for themselves and their children. 
A study from Nigeria reported that 35% of female sex workers are poor and due to the lack 
of food they had accepted unprotected sex with clients (Oyefara, 2007).  
Parallel to this there was a breakdown of family values, with an inclination towards fleeting 
relationships with people that are almost strangers, increasing the possibility of transmitting 
the HIV infection, and therefore women are either infected with HIV because of their 
behavior or due to the "gain" after the debauchery of their peers. 
For many Africans HIV/AIDS is an ethical problem, meaning that it is the result of 
forgetting old values with nature, which enlivened the community before the advent of 
"intellectual" colonialism of the West. 
In Africa, the individual has always been part of a community that has guided the choice of 
a mate and has alleviated the suffering in times of need. With the individualistic approach 
introduced by the Western world, the values which underpin the community have 
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deteriorated and AIDS, a symbol of the corrupt new approach to life, has brought with it a 
tendency to remove the sick from society. 
Discrimination and stigmatization is one of the dramatic consequences HIV/AIDS have to 
face and a major obstacle to prevention and care.  
Women in sub Saharan Africa are more likely to be living with HIV and to access health-
care facilities offering testing, but any decision to implement expanded HIV testing in Africa 
must weight the desired biomedical outcomes of testing against the possibility of 
discrimination (April, 2010). 
Fear of discrimination and stigma causes people to avoid testing and prompts those infected 
with and affected by HIV/AIDS to remain silent, depriving them from essential treatment 
and social care. These problems are perhaps magnified by the existing taboos regarding 
sexuality, affecting more intensively women. 
A woman who discovers she is living with HIV risks, in all parts of the world, losing 
economic support, being abandoned to suffer physical and emotional abuse, of being 
discriminated against and witness her family relationships be destroyed. 
Kilewo et al. (Kilewo et al., 2001) revealed that in Tanzania 77.8% of pregnant women 
infected with HIV participate in trial clinics to avoid maternal fetal transmission, at a 
distance of 18 months after diagnosis they had still not communicated the test result to their 
partners; while during a study carried out in Kenya by Galliard et al.( Galliard et al., 2000), a 
good 76.1% of the interviewed women did not have any intentions in revealing their status'. 
The reasons for the reluctance were fear of abandonment, rejection and discrimination, 
violence, upsetting family members, and accusations of in fidelity (Medley, 2004).  
The diversity of findings between and within populations reflected a wide range of different 
ethnic, cultural and religious groups among the women surveyed, who reported important 
differences in beliefs and preferences relating to formal and informal maternal health care. 
These variations were explained by differences in women in autonomy, gender relationships 
and social networks, which are influenced by embedded social structures, religion and cultural 
beliefs. A woman with HIV who knows her status can make a better choice with regard to her 
reproductive life and, if pregnant, may undergo specific interventions, such as prophylaxis 
with antiretroviral drugs, which significantly reduce the risk of maternal-fetal transmission. 
Clearly, this occurs where there are health services that allow you to see a woman with HIV 
in an appropriate manner in relation to current scientific knowledge. 
At a time when a pregnancy is emerging as a threat to the management, to which requires 
integration of knowledge and technical means, of course we should move to a good 
environment with qualified staff, able to handle the complex clinical problems that the case 
imposes and suitably sensitive to its ethical aspects. 
Neonatal infection remains a terrible scourge for developing countries to poor women who 
receive care during pregnancy and childbirth. 
This state of things pushed 68 priority countries to consider newborn and child health care 
that are part of the Countdown to 2015 Initiative. 
UNICEF, the United Nations Population Fund (UNFPA) and the World Health 
Organization (UNICEF, 2008) recommend at least 4 antenatal care visits during pregnancy, 
during which very little would be sufficient to ensure good health to mother and child, such 
as treatment of hypertension to prevent eclampsia, tetanus immunization, intermittent 
preventive treatment for malaria and distribution of insecticide-treated nets, prevention of 
mother-to-child transmission of HIV, micronutrient supplementation, and birth 
preparedness, including information about danger signs during pregnancy and childbirth. 
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Natural childbirth at home is the only opportunity for many women and even where it is 
possible to perform a Caesarean section, it is unlikely that one may have a proper post-
partum check-up. 
Prevention of mother-to-child transmission of HIV is most effective when antiretroviral 
drugs are received by the mother during her pregnancy and continued through delivery 
and then administered to the infant after birth. 
Every year a million women infected with HIV deliver babies without professional help. 
Marc Bulterys and colleagues suggest here that traditional birth attendants could be 
involved in preventing perinatal transmission of HIV by offering services such as HIV 
testing and counseling and short courses of antiretroviral drugs (Marc Bulterys et al., 2002). 
Antiretroviral drugs are effective in reducing the risk of mother-to-child transmission of 
HIV even when prophylaxis is started for the infant soon after birth. 
The American Academy of Pediatrics recommends documented, routine HIV testing for all 
pregnant women in the United States after notifying the patient that testing will be 
performed, unless the patient declines HIV testing (“optout”consent or “right of refusal”) 
(Committee on Pediatric AIDS, 2008). 
Assuming then that we have taken the test and a pregnant woman is affected by HIV, can 
she refuse to take antiretroviral medicines? 
In the absence of specific laws that impose a compulsory treatment, the principle of 
autonomy recognizes that women have full freedom of choice. 
In a recent study (Cannovo et al., 2010) we faced an emblematic case of a woman suffering 
from HIV who chose to complete her pregnancy notwithstanding a compromised 
pathological clinical picture (diabetes mellitus complicated by nephropathy, retinopathy 
and hypertension prior to conception, history of alcohol abuse and prostitution). 
In this case the self-determination has prevailed over the woman's prescription. 
Another issue that plays a key role in the spread of HIV infection is the FGM / C; For 
UNICEF estimates that in 27 countries of Africa and the Middle East, 70 million girls and 
women aged 15–49 have undergone FGM/C. 
4. Privacy and confidentiality, stigma and discrimination  
The attention to the confidentiality of information towards patients with the human 
immunodeficiency virus involves complex ethical considerations, especially in individuals 
in developing countries, that regardless of nationality, race or custom, each case involves, a 
condition of human confidentiality/secrecy inviolable to be protected if fulfills the 
conditions for the collection of identification data (concerning the identity in the broad 
sense) and sensitive (those suitable to detect the state of health and/or sex life) on HIV 
positive people. 
The topic is complex and ethically sensitive under a human aspect, when speaking of 
subjects located in developing countries and within local communities where the knowledge 
of an infectious disease can result in exclusion from the patient's environment in which they 
live. 
4.1 Legislative approach  
In USA, already in 1997, the Health Insurance Portability and Accountability Act (HIPAA) 
regulations and the Americans with Disabilities Act (ADA) protect people with HIV and 
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their right to control disclosure of their status (Doyal, 1997), then in 2006, the Centers for 
Disease Control and Prevention (CDC) issued revised recommendations for HIV testing of 
adults, adolescents, and pregnant women in health care settings and recommend that opt-
out HIV screening, with no separate written consent, be a routine part of care in all health 
care settings (Hanssens, 2007). 
In 2003, India adopted a specific law for HIV/AIDS covering the ethical, legal and social 
implications of this disease, trying to curb discrimination and stigmatize the disease (The 
Lawyer’s Collective, 2003). 
In 2006, the major world experts in human rights and scientific fields created the Joint 
United Nations Programme on HIV/AIDS and the US President’s Emergency Plan for AIDS 
Relief (PEPFAR) Interim Guidelines on Protecting the Confidentiality and Security of HIV 
Information (UNAIDS, 2007). 
These guide lines focus (Beck et al., 2010) their attention on three aspects, intercurrent 
privacy, confidentiality and security, all facing the protection of sensitive data. 
Privacy has both a legal and ethical concept, since it refers both to data protection provided 
by regulations and to the regulation of access to one's data referring to human rights. The 
Confidentiality is identified with the right of individuals to see their data protected during 
collection, storage, transfer and use in order to prevent unauthorized disclosure of that 
information to third parties. Security refers to technological means by which data is 
protected from inappropriate disclosure. 
The 2008 European Guideline on HIV testing (Poljak, 2009) (2001 update of European 
Guideline for Testing for HIV infection (Thorvaldsen, 2001), approved by the European 
Office of International Union against Sexually Transmitted Infections (IUSTI) and European 
Office of the World Health Organization with the incorporation of various new 
developments) recommends giving HIV test after having complete consent by the person 
who has been informed that the result will remain confidential, but confidentiality is not 
absolute as health-care providers may be legally bound to disclose HIV status information 
in exceptional circumstances (Rogstad, 2006). 
This means that no health professional and / or hospital can refuse to treat or remove a 
patient if HIV positive, and also that the data on their health or sex life may not be 
distributed arbitrarily regardless of the type of experimental study or treatment in place. 
Conversely, however, only if there is prevention, investigation and prosecution of these 
crimes, may it be reported to the competent authorities. 
In literature it was proposed to introduce a coding system that will stand the test of time 
(Sajeev, 2006).  
The non-uniqueness of understanding on the issue of confidentiality of data worldwide, is 
clear thanks to a study conducted in 2007 showing that over 80 countries and UNAIDS 
offices were divided into groups of those who had already issued guidelines on this matter 
(G -countries) and others intending to develop them (NG-countries). 
This research has shown that few countries scaling up HIV services had developed 
guidelines on protecting the confidentiality and security of HIV information at the time of 
completing the survey, but 90% of G-countries had a privacy law against 57% of NG-
countries. 
It should also be noted that even those who have died are entitled to their privacy, since, for 
example, in South Africa, the law does not protect the confidentiality of deceased persons 
(McQuoid-Mason, 2007). 
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It then follows that control over privacy, or the confidentiality of the best data on HIV-
infected patients in the NG-countries, is a huge ethical problem related not only to the socio-
cultural-economic, but also to the inadequacy of the health system, unable to operate due to 
lack of transportation and operators to manage the significant and complex reflections of the 
disease. 
Can one rely on the secrecy, confidentiality, dealing with a phenomenon which is such a 
widespread social alarm? 
It is evident that this extraordinary public importance of HIV obligates behavior, without 
sacrificing the need for knowledge and discussion, to fully respect the dignity of the 
patient/citizen (of any nationality, race), and their fundamental rights. 
Protecting the patient with HIV means allowing the holder of information to freely and 
independently decide the extent to which personal data, which reveals his identity and 
other issues related to his health, can be brought to the attention of others and to control 
treatments to which such data are submitted. 
The HIV epidemic has pushed the affected individuals of the developing world to the 
margins of their societies. Stigma and discrimination can hamper all AIDS patients. 
The secrecy of one's HIV status (crucial point with which people infected with HIV compare 
themselves due to the fear of stigma and discrimination) in populations in developing 
countries, the fear of the news being spread into one's community, increasing the possibility 
of being abandoned, isolated or to alarm and frighten relatives, especially the possibility of 
causing them shame is pushed to a limit.  
This is particularly difficult for some participants because it can lead to the revelation of 
sexual choices up until then lived in secrecy or hiding (because not tolerated by the 
community of origin) or extra-marital relations (sometimes subject to severe punishment), 
with the risk of breaking family ties, loss of economic support or exposed to physical 
violence. 
This condition, in Italy, essentially contains the concept of privacy, according to Rodotà 
(Rodotà, 1991) it provides a set of actions, behaviors, opinions, preferences, personal 
information, on which the applicant wishes to maintain exclusive control, not only to ensure 
confidentiality but to ensure full freedom of choice.  
In much of the world, including some US states and European countries, disclosure by a 
physician of an individual's HIV status without the patient's consent is illegal. In other 
locations, physicians have a duty to warn partners through mandated notification programs. 
Further, professional ethics codes may differ from local laws, complicating these issues. 
In Italy and other European countries there are multiple and meaningful provisions related 
to the main aspects for the protection of privacy relating to the implementation of the 
seropositive and HIV testing. 
In Italy the reporting of AIDS cases is also governed by an ad hoc law (DM 15 December 
1990 and Circular of the Ministry of Health February 27, 1987, 5 and November 25, 1988, 14 
in which restricting the flow of information from the doctor directly to the Regional 
Operations Center and the Ministry of AIDS is clearly marked) and for any transaction 
information only the code number assigned will be used for each case. 
The doctor, investigator, hospital, pharmaceutical company are obliged to respect the 
confidentiality of personal data of the patient. 
When speaking of scientific publications of clinical data or observations relating to 
individuals, the physician should ensure their non-identifiability. 
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The specific consent of the patient applies to any further processing of the data, but only 
within limits, in form and with the exceptions laid down by any standards. 
The assessment must also take into account the historical moment facing the subject 
(environmental, socio-economic and cultural). 
In the event that the subject does not show the capacity of decision to authorize the above, 
the doctor will have to act ethically, ethically with the utmost respect for the dignity of the 
human activating only those projections that protect the patient's health condition of which 
only psycho-physical well-being should result. 
4.2 Psychosocial issues 
Prejudice, exclusion, stigmatization are the three conditions that are still sadly dominant 
both from an individual and social point of view, that is where the community, family, 
friends and the context of membership accepts the condition of the patient with AIDS, it 
could be the patient to perceive and push himself to the point of isolation. 
From a collective point of view, unfortunately, poor information is still a problem that leads 
people to believe that there is a possibility of infection simply being near a person infected 
with HIV. 
Starting from the stigma, over time there has been a change in communication, in fact we 
have moved from the definition of risk groups to risk behavior, shifting attention from 
person to action, with the aim of protecting the individual. Nevertheless, those who contract 
AIDS are labeled for their behavior, but also because, often, the situations are associated 
with promiscuity. Hence the effect that the disease is closely related to the condition of 
homosexuality, therefore, still remains, those who declare their homosexuality live in 
situations of social exclusion for fear of infection, regardless of whether or not they have 
been diagnosed with the disease. 
The situation worsens when the HIV infection is detected, there is exclusion from the family, 
not for fear of contagion, but the condition of homosexuality and the subsequent voluntary 
and conscious exposure to the disease. 
Another recurring problem is the exclusion in relation to meeting new people, the person 
with AIDS avoids meeting new people in order to avoid a situation in which he might have 
to reveal having the disease . Therefore he/she remains anchored to the people who know 
his/her condition, closing himself/herself into a secure network, a micro-cosmos from 
which it is advisable to exit. This is amplified greatly for the couple. For these reasons, it 
often happens that people with AIDS, who may attend self-help groups, prefer to meet up 
with each other even outside of group meetings, forming closed groups and that most of the 
time marginalize themselves from the rest of the community. 
The key problem of AIDS is information, in fact, most often incorrect when speaking about 
infection and transmission, while simultaneously resulting in excessive worry or 
superficiality. It is worrying to know that there are those who think that simply touching or 
sharing space with people with HIV can transmit the disease, in other cases, however, 
actions are taken without considering the risk such as oral sex without using precautions 
In recent years, this omission of information led to an increase of the disease in the 
heterosexual population, as opposed to the homosexual population who have increased 
awareness and therefore paid more attention to prevention. 
In fact, in the case of heterosexuals, not perceiving the risk of infection not belonging to "risk 
groups", lowers the threshold of concern and risky actions are performed such as 
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unprotected oral sex. It is not usual to see a heterosexual test for HIV, among gay people, 
however, the test has become routine every six months, promoting early diagnosis and 
therefore a more effective treatment, but, above all, preventing the risk of infection for 
potential partners. 
Consequently, even the onset of the disease is different, in fact in many cases it occurs that 
heterosexual couples discover infection when taking AIDS diagnostic tests related to 
pregnancy or when clinical problems in either partner occur. 
Another equally problematic aspect is thee moment in which the news is given, it may 
provoke reactions of fear, fear of death and social problems.  
The news of the disease can occur in three ways: a) the subject goes to a specialized center 
for testing; b) the person takes the test in any laboratory and c) the patient performs checks 
due to medical conditions. 
In the first case the news is given to personnel who then takes charge of the patient, 
providing in-depth information on the disease and on all related issues and support with 
psychological support. 
In the second case, the person often reads the result on a sheet of paper that reads HIV: 
positive and from that moment a long and painful ordeal begins, marked by confusion and 
disorientation, not knowing, knowing little or not well informed causing more fear,until the 
person hopingly reaches a structure where people are able to respond and support him. 
In this case, unfortunately, the news of the disease may push the patient to respond with 
suicide. 
In the third case the patient receives the news from a point which sends him to specialized 
facilities that take care of providing assistance and support, but in all cases, the news of the 
disease results in anxiety due to the severe loss, fear of what is happening and the absence 
of certainty. 
We often associate related disorders such as manic depression, mood disorders and anxiety 
disorders, however, the psychological effects of the news vary according to previous living 
conditions, in fact, the more prosperous the person, having had both a safe emotional, social 
and work condition, the more the disease is the collapse of everything he had built and is 
plunged into the abyss of self-destruction. This also happens in cases where behavior risks 
are a reaction of anxiety due to suffering and uncomfortable situations. In any case, 
following diagnosis is an internal reorganization of forces, not only to address all the threats 
and fears related to the disease, but to address those old ghosts that re-emerge at this time, 
all the unresolved issues that suddenly emerge, the fears of abandonment, etc.. 
After the illness is metabolized and after processing coping strategies, fluctuating moments 
will follow, alternating from calm periods to periods dominated by the uncertainty that 
determines hypochondria and panic and every little discomfort is associated with 
threatening entities. 
Studies show that women suffer more prejudice and discrimination than being actually 
infected with HIV, they are most at risk with regard to the possibility of having more 
aggressive and dangerous forms of the disease and having a harder time dealing with this 
situation. 
Finally, though in recent years it is increasingly common to see women facing a pregnancy 
and giving birth to children immune to the virus, it is easy to imagine the effort that a 
woman must make for such a challenging and important project like having a child, 
knowing that their health can be a burden, an obstacle during their child's growth, perhaps 
even during these sensitive stages in which it is essential that a mother is near and present.  
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It follows that the progress and results discovered about AIDS are important and significant. 
However, there should be more emphasis on information and communication so as to 
prevent low levels of attention, while it is important to create a welcoming social network 
and cooperation that will ensure that those who are infected with HIV are not in situations 
of isolation, hardship and distress.  
5. Role of different stakeholders in improving health care and health 
information in HIV/AIDS patients 
Decision-making about controversial public health projects may thus be primarily a function 
of emotional reactions to drug addicts of disgust, dehumanization and stigmatization rather 
than reactions of sympathy, humanity and the right to optimal health for all.  
Within a disgust/dehumanization framework, effectiveness and cost-effectiveness are 
usually not important aspects of a program or policy. Rather, it is the congruency between 
the symbolic value of the program and the emotions of disgust, dehumanization and 
stigmatization that is critical. 
As well pointed out by Soldini (Soldini, 2001), when speaking about the HIV/AIDS 
infection, issues of health policy are "the result of the ethical debate" that will have to 
provide the necessary and essential arguments in order to draft a legislation that provides 
appropriate solutions to curb the problems that characterize this infection. 
We must, therefore, even before acting on a deontological and legal level, with health care 
professionals, behave ethically responsible towards patients with HIV/AIDS. 
They only needs to be respected with dignity as human beings and their rights can not be 
disregarded in any way, diminished or taken away just because of their infection status. 
In the world there is a huge difference between countries on how HIV is handled, 
specifically when speaking about the laws on testing, the use of informed consent, data 
confidentiality, notification of decisions, and ultimately support . 
The Recommendations (2006) of the Centers for Disease Control and Prevention (CDC) 
suggest testing for HIV with the tests carried out routinely during the hospitalization of an 
inmate, serving as a battering ram against the wall of silence that makes being infected by 
the HIV disease, "exceptional. " 
Suffice it is to say that informed consent can be considered valid even if the patient gives a 
general consent at the moment in which he decides to go under medical activity, starting 
from the definition provided by the American Medical Association, that informed consent is 
“a process of communication between a patient and physician that results in the patient’s 
authorization or agreement to undergo a specific medical intervention (American Medical 
Association, 2008)”. 
Clearly, this assertion does not consider the difference between informed consent in general 
and those relative to specific situations, which then contextualizes the patients' expression of 
will to where they live; there is not an easy application form for these regulatory differences, 
and it could become a standard care, but we must not forget the elements of the tripod that 
support its HIV exceptionalism - which, incidentally, we have already spoken of- 
counseling, informed consent and confidentiality. 
Not all states that claim the patient's consent for testing, provide counseling, limiting for 
example, only positive cases - as in California (Maine Revised Statues, 2008) - wasting the 
opportunity to help prevention in a slice of the population who still may be at risk, even if 
the response is negative. 
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Finally, confidentiality and notification of results to interested parties are issues of 
fundamental importance that can not be left to the good sense of the person concerned. 
In USA (Li et al., 2007) there are ethnic differences with respect to the disclosure process, for 
example, Hispanics are more likely than African Americans and Caucasians, to 
communicate a positive diagnosis to their relatives in order to prevent spread of infection in 
the family clan, while Asian Americans, in relation to their culture, ethnic community and 
their family role have difficulty coping with the problem. Generally, the reason that drives a 
person to speak comes from the desire to preserve the family from infection, but there is a 
difference in how these communities in the U.S and Asian countries of origin behave. It is 
more difficult than having an unintended revelation in the USA where the reporting 
guidelines are very strict. 
In Asian countries there is more reluctance because discrimination is not only found in the 
family but also in the community, which also ends up pressuring the family clan. 
In China, thanks to the "Four Free One Care" national campaign promoted by the 
Government, a greater awareness is growing with family involvement in accepting not only 
infection but also in preventing the spread of infection (UNAIDS, 2004). 
On this issue it is worth reporting the example of the State of New York, where the District 
Health Officer is in charge of tracking the individuals concerned and notifying the results if 
a patient has received a positive response to the HIV test. 
Another case in point is represented in South Africa, where the State guarantees the post-
exposure prophylaxis treatment (PEP) only to those who meet the definition of “appropriate 
victimhood”, while complicating access by those regarded as co-responsible for their 
predicament and accordingly as undeserving of treatment (Pieterse, 2010). 
Today, the HIV battle is won with information and training, both of which are attributable 
to public institutions; providing HIV screening programs will allow a hand to save more 
lives by ensuring patients right to care and help their partners stay safe, the other to save 
public funds and assist people with full blown AIDS now no longer negotiable. 
Civil rights must be incorporated in the laws as was the case in Iran (Zare & Mortazavifar, 
2010) where the constitution (principles 19, 20, 28, paragraph 42 and paragraph 4 of article 6, 
article 43) have been used in several types of international declarations (es. Universal 
Declaration of Human Rights, Convention on the Elimination of all types of discrimination 
against women). 
As Brown emphasizes, “as that base of scientific literature and public health practice 
literature grows, and given emerging scientific evidence supporting increate testing as a 
cost-effective public health measure, legislators and medical communities must work 
together to ensure that legislation in all states supports the ability to offer large-scale ED 
HIV testing” (Brown, 2008). 
Therefore only when the government and health professionals can ensure the confidentiality 
and security of HIV information collected in community or health facilities and information 
repositories, more people will decide to get themselves tested for HIV and to go to 
assistance and prevention centers created for people with risk of infection (Hargreaves, 
2007). The privacy law serves as a legal blueprint to establish policy practices (Stewart, 
1988), but the application of and education about the law may require various strategies, 
which countries must study and implement. This is perhaps the main task to which the 
states are called to carry out, and that may eventually be the key to defeating the 
indiscriminate spread of HIV infection. 
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6. Conclusions 
HIV infection, resulting in AIDS is a special event that involves elements that are very 
personal to the people who come in contact, which also involves upheavals on the 
biographical, psychological, social and cultural sphere, not just on the person who 
contractes the disease (who is also found himself in having to radically change his habits) 
but also on his family and people who are close, which may not be prepared to face a 
difficult and delicate problem as far as that treaty. 
In fact, the infection can occur through physical contact between two people, mediated or 
not by a syringe or a bag of blood, or through unprotected sex with people already infected. 
According to popular imagination, these people belong to that particular category of 
outsiders, such as drug addicts, prostitutes or persons in serious economic difficulties, 
which unfortunately in our society tend to be seen as persons "guilty" who deserve to be 
expelled from the "healthy" community which is regulated by "moral" principles that 
outsiders would infringe with "disgraceful" conduct. 
The Greek word encompasses, through the richness of a language, most of the original 
concept just said. In fact, this word is translated with the Italian word "brand", therefore 
something that identifies a person negatively, or even with "tattoo" a particular sign and 
distinctive easily detectable, or even the "spot", either physical or moral, or, finally, 
surprisingly, with the word "bite", as if to predict a mode of transmission of this disease. 
It is therefore the "stigma" of HIV or AIDS that is pushing away the very people who should 
be helped and protected by society, the weakest that most easily feel their fundamental 
rights of equality and health are being mined from those with whom they should be living 
with, with the consequence of continuously being pushed outside that fundamental network 
that gives support and relief in such delicate moments. One of these is the shocking moment 
in which the patient receives the bad news of having contracted an incurable disease. 
Fearing expulsion from society and from affection, it is logical and natural that people who 
have a "risky" behavior, are normally not the ones who spontaneously take tests to check 
something. Something that could make them "outsiders", even at the risk of not knowing 
whether they have actually contracted the disease and give up immediately to treatment. 
Treatments that could delay the onset of much of the disease, to avoid infecting people who 
are close to them and even to give or to unknowingly give their partner an infant that would 
otherwise be born healthy, since you can prevent the transmission vertical mother-fetus if 
the virus is recognized beforehand. Another problem then is the "self stigmatization" that 
can affect those who discover they have contracted the disease and as a result of this 
discovery decide to isolate themselves because they are considered a danger to their loved 
ones, or because they feel "ashamed". In addiction, a psychological breakdown is hardly be 
avoided in the absence of adequate information and assistance for this purpose. 
The peculiarities of the consequences of this disease and the difficulties of a curative and 
preventive approach are exacerbated by the cultural attitude and anthropological-ethical 
territory in which you are studying, whether it is an industrialized country, or a developing 
country, because besides the differences already discussed in previous sections, the 
problem of the "stigma" unites these two heterogeneous realities. If we should promote, 
from a cultural point of view, a real campaign against the stigma of living with HIV or 
AIDS, with appropriate counseling offered to those who may be in need, as well as the 
stigmatization of any other carrier of incurable diseases and, more generally, " different, 
"the ethical side should be able to resolve a painful impasse, constituted by the problem of 
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how to balance the privacy rights on the highly sensitive data such as those relating to 
health, or, in other words, the confidentiality of the results of examinations, with the 
principle of beneficence, which, as evidenced by Ngotho (Ngotho, 2009) , may have both 
negative and positive aspects. Ngotho writes that the success of the different policies will 
depend on the mutual entirely respect for confidentiality of the patients' care that flows 
from the patient to medical practitioner". Assuming that the doctor must always pursue 
the good of the patient, must he behave as if he knows that the patient is suffering from 
HIV or AIDS? It is his duty to inform the community and identify those who are ill or 
who may have been infected to get them to start care and prevent them from spreading 
the infection, even at the risk of going against the right to self-determination and privacy 
of his patient? Is it right to leave the doctor alone to face this problem without giving him 
the measures to make this choice less excruciating? 
Or, is it ethically acceptable to transform the HIV test into a routine examination for all 
admissions or for all pregnant women, perhaps preceded and followed by ad hoc 
counseling, as discussed by Salari and Azizi (Salari & Azizi, 2009) useful to try to balance 
the right of women to self-determination with the right to health of the unborn? But if such 
tests were to become routine, will the request of the informed consent of the patient mark 
the difference between the bid, rather than the imposition of such a test, or it could it even 
further stigmatize people with HIV/AIDS, as noted by Bayer and Edingtoni (Bayer & 
Edington, 2009)? 
The Code of Medical Ethics of the American Medical Association (opinion 5.5) and global 
politics tend to affirm the principle that the health information the doctor comes to learn 
must remain confidential unless it is ethically and legally justifiable its disclosure, to avoid 
undermining the doctor-patient relationship which is based primarily on trust. But can the 
preservation of that relationship based on trust be considered a priority even in the case of 
HIV or AIDS, where it is not only questioning the patient's health, but also the entire 
community? It rises so difficult to answer another question that has always interested the 
discussion on bioethics, one of whose leading exponents is the famous bioethicist Hans 
Jonas (Jonas, 1997), namely the balance between the interests of the individual with the 
interests of the entire community, that can be summarized in the question: when must the 
right to the common good take precedence over the right of the individual? 
This problem has already been extensively discussed in bioethics in respect of 
experimentation with human beings, which so far has always tried to protect the rights of 
the individual more than the community, except in regard to cases of highly contagious or 
infectious diseases, where instead it is intended to give precedence to the good of the 
community over the rights of the individual that necessarily weakens the protection of 
human health. One may wonder then if this is the case HIV or AIDS. 
Still, one may wonder what is respectful of another pivotal principle of bioethics, to allow 
individuals the freedom to announce or not having the infection, leaving the responsibility 
to indirectly complicit in a "murder" ? How must doctors react when they do not not agree 
with the decision of the patient to not inform their partners of the future infection? 
As for the principle of autonomy, another key element of bioethics, which has always 
stressed the importance of self-determination of the patient, can this be protected in cases 
where the patient's autonomy may be lethal to other human beings? 
But these are not the only problems that arise when one is confronted with various and 
diverse effects of HIV and AIDS. 
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As noted above, other issues may arise again, but much more complicated because they are 
linked to economic and historical issues, when considering the differences in approach to 
the prevention, diagnosis and study of the phenomenon of HIV and AIDS in industrialized 
and developing countries. In this case, the principle of fairness should never be broken in a 
society that respects the dignity of human beings, one of its hinges, and it can not take 
second place in the financial resources of a country. Health is a decisive factor for the 
development of human beings, families and communities throughout the world and you 
can not imagine a civil and human progress without respect for the fundamental right to 
health that is inherent to every human being regardless of his economic possibilities, of the 
place where he was born or is living or his social status. 
No law nor the Universal Declaration can ever resolve the problems and discrimination 
facing people living with HIV or AIDS until each individual is allowed to heal properly, and 
while deep divisions continue to exist between ethics and law, between theory and practice, 
between individual rights and community rights, which can not be resolved by common 
ethical thinking, but they need the active and conscientious participation of the 
economically more advanced countries that have more resources to combat this 
phenomenon. 
Only by launching a trans-national dialogue on ethical and social aspects of HIV/AIDS with 
the aim of building a consensus on policies to be implemented, to address this pandemic 
and to achieve more shared laws -  not only to help the individuals with the disease and the 
people close to them at risk of infection, but the doctors called for the diagnosis, prevention, 
treatment and progress of the search for a cure - both the right of individuals to privacy and 
self-determination and the right to health of the general community can be guaranteed 
without hateful discrimination based on the economic, historical and social structures of a 
country. 
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